| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 25,336,505 | 28,634,180 | 21,735,760 | | Cost of Revenue | 10,703,635 | 12,165,170 | 10,147,138 | | | Gross Profit | 14,632,870 | 16,469,010 | 11,588,623 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,567,793 | 4,888,450 | 3,580,955 | | Non Recurring |
-
|
-
|
-
| | Others | 3,061,544 | 3,751,200 | 2,517,771 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,003,533 | 7,829,360 | 5,489,898 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (690,404) | 44,666 | 548,298 | | Earnings Before Interest And Taxes | 6,313,129 | 7,884,616 | 6,038,195 | | Interest Expense | 1,053,218 | 707,351 | 845,938 | | Income Before Tax | 5,259,911 | 7,177,265 | 5,192,258 | | Income Tax Expense | 1,291,254 | 2,068,864 | 1,552,849 | | Minority Interest | (6,589) | (10,093) | (7,828) | | | | Net Income From Continuing Ops | 3,970,088 | 5,093,013 | 3,634,960 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,970,088 | 5,093,013 | 3,634,960 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,970,088 | $5,093,013 | $3,634,960 |
|
0.49% Nasdaq 
Income Statement
